IONIS PHARMACEUTICALS INC
For the period ended Jun 30, 2024. Filed Aug 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 1, 2024
IONS$39.42+1.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signatures | Title | Date | |
|---|---|---|---|
| /s/ BRETT P. MONIA | Director and Chief Executive Officer | ||
| Brett P. Monia, Ph.D. | (Principal executive officer) | August 1, 2024 | |
| /s/ ELIZABETH L. HOUGEN | Executive Vice President, Finance and Chief Financial Officer | ||
| Elizabeth L. Hougen | (Principal financial and accounting officer) | August 1, 2024 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.